老年人 PFP 2 疫苗的三个剂量水平之一-猫眼课题宝

老年人 PFP 2 疫苗的三个剂量水平之一

批准号：

6115621

负责人：

KATHLEEN M NEUZIL

金额：

$3.64万

依托单位：

VANDERBILT UNIVERSITY

依托单位国家：

美国

项目类别：

财政年份：

1998

资助国家：

美国

项目状态：

已结题

起止时间：

1998-12-01 至 1999-11-30

来源：

https://reporter.nih.gov/project-details/6115621

关键词：

antibody formation antibody neutralization test antibody titering clinical research dosage drug screening /evaluation human old age (65+) human subject respiratory syncytial virus viral vaccines

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Evaluate the safety of three doses of PFP-2 in ambulatory elderly subjects and determine and compare antibody titers to RSV as measured by EIA-F and Neutralization (Nt) assays to RSV-A and RSV-B after a single injection of one of three different dosage levels formulations (50, 25, or 10 ug) of PFP-2. We have completed one phase of this study and will be starting the next one after the influenza season has subsided as not to confound data.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文